BUZZ-AbbVie rises on quarterly profit beat

AbbVie, Inc.

AbbVie, Inc.

ABBV

0.00

** Shares of drugmaker AbbVie ABBV.N rise 2.5% to $202 premarket

** Co reports Q1 adj. profit of $2.65 per share vs. analysts' average estimate of $2.59 per share - LSEG data

** ABBV's quarterly revenue of $15 billion beats analysts' average expectation of $14.72 billion

** Upbeat results driven by strong demand for ABBV's newer immunology drugs, Skyrizi and Rinvoq

** Co raises annual adjusted profit forecast to a range of $14.08 to $14.28 per share from $13.96 to $14.16 per share earlier

** Up to last close, stock down 13.5% YTD



This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.